Segmentation by type classifies Histology Service offerings into routine processing, immunohistochemistry (IHC), special stains, molecular histology, and digital pathology services. Routine processing, the foundational service, includes tissue fixation, embedding, sectioning, and standard hematoxylin‑eosin staining, and underpins roughly 40 % of total market volume due to its universal requirement across all applications. IHC, which adds antigen‑specific antibodies to visualize protein expression, contributes about 25 % of market value, reflecting its critical role in targeted therapy selection and biomarker research. Special stains, such as PAS, Masson's trichrome, and reticulin, represent 15 % of revenue, addressing niche diagnostic needs for connective tissue and microbial identification. Molecular histology, integrating DNA/RNA extraction with histological context, accounts for 12 % of the market, driven by the rise of spatial genomics. Finally, digital pathology services—encompassing slide scanning, image analysis, and telepathology—hold a 8 % share, as healthcare providers adopt AI‑enabled workflows for efficiency and remote consultation.